|
|
Volumn 63, Issue 23, 2006, Pages
|
|
Genetics examined in tamoxifen's effectiveness: Recurrence warning urged for labeling
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANTIDEPRESSANT AGENT;
AROMATASE INHIBITOR;
CYTOCHROME P450 2D6;
ESTROGEN RECEPTOR;
FLUOXETINE;
LETROZOLE;
PAROXETINE;
SERTRALINE;
TAMOXIFEN;
ALLELE;
BREAST CANCER;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER RELAPSE;
CARCINOMA IN SITU;
DRUG EFFICACY;
DRUG LABELING;
DRUG METABOLISM;
DRUG SAFETY;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
GENOTYPE;
HUMAN;
NOTE;
POSTMENOPAUSE;
PRIORITY JOURNAL;
|
|
EID: 33845190830
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news060026 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|